Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years-Reference-Cited by-同舟云学术

Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years

Published:2021-02-01 Issue:2 Volume:181 Page:179
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Yourman Lindsey C.¹,Cenzer Irena S.²,Boscardin W. John²³,Nguyen Brian T.²³⁴,Smith Alexander K.²³,Schonberg Mara A.⁵⁶,Schoenborn Nancy L.⁷,Widera Eric W.²³,Orkaby Ariela⁷⁸⁹,Rodriguez Annette²³⁴,Lee Sei J.²³

Affiliation:

1. Division of Geriatrics and Gerontology, School of Medicine, University of California, San Diego

2. Geriatrics, Palliative and Extended Care Service Line, San Francisco VA (Veterans Affairs) Health Care System, San Francisco, California

3. Division of Geriatrics, School of Medicine, University of California, San Francisco

4. Northern California Institute for Research and Education, San Francisco

5. Department of Medicine, Harvard Medical School, Cambridge, Massachusetts

6. Department of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts

7. Division of Geriatric Medicine and Gerontology, School of Medicine, John Hopkins University, Baltimore, Maryland

8. New England GRECC (Geriatrics Research, Education and Clinical Center), VA Boston Healthcare System, Boston, Massachusetts

9. Division of Aging, Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2773065/jamainternal_yourman_2020_oi_200086_1611344100.5702.pdf

Reference51 articles.

1. 2017 ACC/AHA blood pressure treatment guideline recommendations and cardiovascular risk.;Colantonio;J Am Coll Cardiol,2018

2. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.;Bibbins-Domingo;JAMA,2016

3. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.;Grundy;J Am Coll Cardiol,2019

4. Statin-associated side effects.;Thompson;J Am Coll Cardiol,2016

5. Potential drug-drug interactions in older adults: a population-based study.;Santos;Geriatr Gerontol Int,2017

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing frailty from laboratory into real world: A critical step toward frailty‐guided clinical care of older adults;Journal of the American Geriatrics Society;2024-08-21

2. Treating Hypercholesterolemia in Older Adults for Primary Prevention of Cardiovascular Events;Drugs & Aging;2024-08-10

3. Age, sex, and multi-morbidity stratified mortality risk estimates for adults with cerebral palsy to inform clinical decision making;Disability and Health Journal;2024-08

4. Cholesterol Lowering in Older Adults: Should We Wait for Further Evidence?;Current Atherosclerosis Reports;2024-07-03

5. The role of statin therapy in older adults: best practices and unmet challenges;Expert Review of Cardiovascular Therapy;2024-07